Patrick McCall
Director of Finance/CFO bij IN8BIO, INC.
Vermogen: 31 571 $ op 31-03-2024
Profiel
Patrick McCall is currently the Chief Financial Officer & Secretary at IN8bio, Inc. Prior to his current position, he worked as the Controller at Catalyst Biosciences, Inc. and as the Vice President-Finance at Turnstone Biologics Corp.
from 2018 to 2021.
Mr. McCall completed his undergraduate degree at Drexel University and holds an MBA from Cornell University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
IN8BIO, INC.
0.06% | 07-02-2024 | 26 755 ( 0.06% ) | 31 571 $ | 31-03-2024 |
Actieve functies van Patrick McCall
| Bedrijven | Functie | Begin |
|---|---|---|
| IN8BIO, INC. | Director of Finance/CFO | 08-02-2021 |
Eerdere bekende functies van Patrick McCall
| Bedrijven | Functie | Einde |
|---|---|---|
| TURNSTONE BIOLOGICS CORP. | Director of Finance/CFO | 01-02-2021 |
| CATALYST BIOSCIENCES | Comptroller/Controller/Auditor | - |
Opleiding van Patrick McCall
| Drexel University | Undergraduate Degree |
| Cornell University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TURNSTONE BIOLOGICS CORP. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Catalyst Biosciences, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA. | Health Technology |
| IN8bio, Inc. |
